3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 3
1
Status
Terminated
1
Recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Breast
1
Conditions
Neoplasm Metastasis
1
Myelodysplastic Syndromes
1
Leukemia, Myeloid, Acute
1
Leukemia
1
Breast Neoplasms
1
Interventions
pembrolizumab
1255
Specimen Handling
871
Carboplatin
820
Magnetic Resonance Spectroscopy
809
Cyclophosphamide
799
Cisplatin
719
Nivolumab
645
Paclitaxel
626
Radiotherapy
565
Gemcitabine
563
Biopsy
532
Bevacizumab
471
Dexamethasone
435
fludarabine
406
Docetaxel
370
venetoclax
365
Oxaliplatin
362
Fluorouracil
353
Capecitabine
350
atezolizumab
342
Rituximab
329
durvalumab
328
Doxorubicin
314
Radiosurgery
306
Pemetrexed
303
Drug Therapy
294
Standard of Care
293
Ipilimumab
288
Etoposide
279
Radiation
279
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Interventional
×
Association
×
1 year
×
Clear all
NCT01613482
2026-03-16
TSARINE
Centre Oscar Lambret
Phase 3
Terminated
13 enrolled
NCT06022016
2025-12-08
LUCID
Institut Claudius Regaud
Phase NA
Recruiting
910 enrolled